60
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Tumor Grade Heterogeneity in Urothelial Bladder Carcinoma?Proposal of a System Using Combined Numbers

Pages 275-279 | Published online: 09 Jul 2009

References

  • Epstein JI, Amin MB, Reuter VR, Mostofi FK and the consensus conference committee. The World Health Organization/International Society of Urological Pathol-ogy consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22: 1435–48.
  • Abel PD, Henderson D, Bennett MK, Hall RR, Williams G. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol 1988; 62: 339–42.
  • Ooms ECM, Anderson WAD, Alons CL, Boon ME. Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 1983; 14: 140–3.
  • Robertson AJ, Beck JS, Burnett RA, Howatson SR, Lee FD,Les sells AM, et al. Observer variability inhistopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol 1990; 43: 17–21.
  • Mostofi FK, Davis CJ, Sesterhenn IA. Histological typing of urinary bladder tumours. Geneva, World Health Organization. 2nd ed. Berlin Heidelberg: Spring-er-Verlag; 1999. p.10–11.
  • International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. Sobin LH, Witte-kind Ch, editors. 5th ed. New York: Wiley-Liss, 1997. p.187–90.
  • Lapham RL, Grignon D, Ro JY. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Sem Diagn Pathol 1997; 14: 109–22.
  • Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer 1987; 60: 2766–74.
  • Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladder tumours. Geneva. International Histo-Health Organization; 1973. p.15–19.
  • Murphy WM, Beckwith JB, Farrow GM. Tumors of thekidney, bladder, and related urinary structures. In: Atlas of tumor pathology. 3rd series, fascicle 11. Washington DC: Armed Forces Institute of Pathology; 1994. p. 211� 19.
  • Malmstro�m PU, Busch C, Norle�n BJ. Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with �5-year follow-up. Scand J Urol Nephrol 1987; 21: 185�95.
  • Bergkvist A, Ljungqvist A, Moberger G. Classi. cation of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371�8.
  • Young RH, Eble JN. Tumors of the urinary tract. In: Fletcher CDM, ed. Diagnostic histopathology of tumors. Edinburgh: Churchill Livingstone, 1995. p. 372�88.
  • Gleason DF, Mellinger GT and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58�64.
  • Billis A, Carvalho RB, Mattos AC, Negretti F, Nogueira CR, Oliveira MCBM, et al. Grading of urothelial bladder carcinoma. Proposal of a system using combined numbers. Mod Pathol 1998; 11: 76A (abstract).
  • Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 2000; 88: 1663�70. Scand

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.